Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway.
Wang L, Wang Y, Chen A, Teli M, Kondo R, Jalali A, Fan Y, Liu S, Zhao X, Siegel A, Minami K, Agarwal M, Li BY, Yokota H.
Wang L, et al. Among authors: jalali a.
FASEB J. 2019 Dec;33(12):13710-13721. doi: 10.1096/fj.201901388R. Epub 2019 Oct 4.
FASEB J. 2019.
PMID: 31585508
Free PMC article.
Bone is a frequent site of metastasis from breast cancer, and a desirable drug could suppress tumor growth as well as metastasis-linked bone loss. ...-Wang, L., Wang, Y., Chen, A., Teli, M., Kondo, R., Jalali, A., Fan, Y., Liu, S., Zhao, X., Sie …
Bone is a frequent site of metastasis from breast cancer, and a desirable drug could suppress tumor growth as well as metastas …